Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewAmsterdam Pharma (NAMS) Intangibles (2022 - 2023)

Historic Intangibles for NewAmsterdam Pharma (NAMS) over the last 2 years, with Q2 2023 value amounting to $88887.8.

  • NewAmsterdam Pharma's Intangibles changed N/A to $88887.8 in Q2 2023 from the same period last year, while for Jun 2023 it was $88887.8, marking a year-over-year change of. This contributed to the annual value of $84.8 million for FY2022, which is N/A changed from last year.
  • Per NewAmsterdam Pharma's latest filing, its Intangibles stood at $88887.8 for Q2 2023.
  • NewAmsterdam Pharma's Intangibles' 5-year high stood at $84.8 million during Q4 2022, with a 5-year trough of $88887.8 in Q2 2023.